Описание
Assessment of endothelial function following SIRT1 pharmacological activation in MTHFR-deficient conditions. Vasorelaxation responses indicate that SIRT1 activation may partially rescue the impaired vascular reactivity observed in MTHFR deficiency.
Figure 2
ChartSource Paper
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.Cite This Figure
![Figure 2: Assessment of endothelial function following SIRT1 pharmacological activation in MTHFR-deficient conditions. Vasorelaxation responses indicate that SIRT1 activation may partially rescue the impaired vascular reactivity observed in MTHFR deficiency.]() > Source: Albino Carrizzo et al. "SIRT1 pharmacological activation rescues vascular dysfunction and prevents throm." *Cellular and molecular life sciences : CMLS*, 2022. PMID: [35821533](https://pubmed.ncbi.nlm.nih.gov/35821533/)
<figure> <img src="" alt="Assessment of endothelial function following SIRT1 pharmacological activation in MTHFR-deficient conditions. Vasorelaxation responses indicate that SIRT1 activation may partially rescue the impaired vascular reactivity observed in MTHFR deficiency." /> <figcaption>Figure 2. Assessment of endothelial function following SIRT1 pharmacological activation in MTHFR-deficient conditions. Vasorelaxation responses indicate that SIRT1 activation may partially rescue the impaired vascular reactivity observed in MTHFR deficiency.<br> Source: Albino Carrizzo et al. "SIRT1 pharmacological activation rescues vascular dysfunction and prevents throm." <em>Cellular and molecular life sciences : CMLS</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35821533/">35821533</a></figcaption> </figure>